Next Article in Journal
N. meningitidis and TLR Polymorphisms: A Fascinating Immunomodulatory Network
Next Article in Special Issue
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
Previous Article in Journal
Comprehensive Characterization of Reference Standard Lots of HIV-1 Subtype C Gp120 Proteins for Clinical Trials in Southern African Regions
Previous Article in Special Issue
Coupling Peptide Antigens to Virus-Like Particles or to Protein Carriers Influences the Th1/Th2 Polarity of the Resulting Immune Response
Article Menu

Export Article

Open AccessReview
Vaccines 2016, 4(2), 19; doi:10.3390/vaccines4020019

Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses

Department of Chemistry and Biochemistry, School of Green Chemistry and Engineering, University of Toledo, Toledo, OH 43606, USA
Author to whom correspondence should be addressed.
Academic Editor: Diane M. Harper
Received: 10 April 2016 / Revised: 10 May 2016 / Accepted: 12 May 2016 / Published: 20 May 2016
(This article belongs to the Special Issue Glycopeptide-based and Related Vaccines)
View Full-Text   |   Download PDF [738 KB, uploaded 20 May 2016]   |  


Carbohydrates are regarded as promising targets for vaccine development against infectious disease because cell surface glycans on many infectious agents are attributed to playing an important role in pathogenesis. In addition, oncogenic transformation of normal cells, in many cases, is associated with aberrant glycosylation of the cell surface glycan generating tumor associated carbohydrate antigens (TACAs). Technological advances in glycobiology have added a new dimension to immunotherapy when considering carbohydrates as key targets in developing safe and effective vaccines to combat cancer, bacterial infections, viral infections, etc. Many consider effective vaccines induce T-cell dependent immunity with satisfactory levels of immunological memory that preclude recurrence. Unfortunately, carbohydrates alone are poorly immunogenic as they do not bind strongly to the MHCII complex and thus fail to elicit T-cell immunity. To increase immunogenicity, carbohydrates have been conjugated to carrier proteins, which sometimes can impede carbohydrate specific immunity as peptide-based immune responses can negate antibodies directed at the targeted carbohydrate antigens. To overcome many challenges in using carbohydrate-based vaccine design and development approaches targeting cancer and other diseases, zwitterionic polysaccharides (ZPSs), isolated from the capsule of commensal anaerobic bacteria, will be discussed as promising carriers of carbohydrate antigens to achieve desired immunological responses. View Full-Text
Keywords: T-cell dependent immune response; zwitterionic polysaccharides; carbohydrate-based vaccines; PS A1 T-cell dependent immune response; zwitterionic polysaccharides; carbohydrate-based vaccines; PS A1

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Nishat, S.; Andreana, P.R. Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses. Vaccines 2016, 4, 19.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top